SUBSCRIBE
SUBSCRIBE
Kyle Holen

Kyle Holen

Opinion author

Kyle Holen, MD, is Moderna’s head of development for therapeutics and oncology.

mRNA leaves the nucleus, it moves to a ribosome 3d rendering
Opinion
How mRNA Can Help Bridge the Innovation Gap in Rare Disease
As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases that lack approved treatments.
February 28, 2025
 · 
3 min read
 · 
Kyle Holen